Holding a MIR ror up to the robustness of the prostate cancer urinary transcriptome

Adele E Connor^{1

2}, Asia C Jordan^{1

2}, Antoinette S Perry^{1

2}

Affiliations

¹ School of Biology and Environmental Science, University College Dublin, Dublin, Ireland.
² Cancer Biology and Therapeutics Laboratory, Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin, Ireland.

Editorial

Adele E Connor et al. Transl Androl Urol. 2019 Dec.

. 2019 Dec;8(Suppl 5):S488-S490.

doi: 10.21037/tau.2019.09.25.

Adele E Connor^{1

2}, Asia C Jordan^{1

2}, Antoinette S Perry^{1

2}

¹ School of Biology and Environmental Science, University College Dublin, Dublin, Ireland.
² Cancer Biology and Therapeutics Laboratory, Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin, Ireland.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Urinary biomarkers in prostate cancer: to the miRnome and beyond.
Hoey C, Jeyapala R, Boutros PC, Bapat B, Liu SK. Hoey C, et al. Transl Androl Urol. 2020 Apr;9(2):843-845. doi: 10.21037/tau.2019.11.25. Transl Androl Urol. 2020. PMID: 32420197 Free PMC article. No abstract available.

Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.
Jeon J, Olkhov-Mitsel E, Xie H, Yao CQ, Zhao F, Jahangiri S, Cuizon C, Scarcello S, Jeyapala R, Watson JD, Fraser M, Ray J, Commisso K, Loblaw A, Fleshner NE, Bristow RG, Downes M, Vesprini D, Liu S, Bapat B, Boutros PC. Jeon J, et al. J Natl Cancer Inst. 2020 Mar 1;112(3):247-255. doi: 10.1093/jnci/djz112. J Natl Cancer Inst. 2020. PMID: 31161221 Free PMC article.

1. Van Neste L, Hendriks RJ, Dijkstra S, et al. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score. Eur Urol 2016;70:740-8. 10.1016/j.eururo.2016.04.012 - DOI - PubMed
1. Hessels D, Klein Gunnewiek JM, van Oort I, et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-15; discussion 15-6. 10.1016/S0302-2838(03)00201-X - DOI - PubMed
1. McKiernan J, Donovan MJ, O'Neill V, et al. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy. JAMA Oncol 2016;2:882-9. 10.1001/jamaoncol.2016.0097 - DOI - PubMed
1. O'Reilly E, Tuzova AV, Walsh AL, et al. epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer. JCO Precis Oncol. 2019;2019. doi: .10.1200/PO.18.00134 - DOI - PMC - PubMed
1. Connell SP, Hanna M, McCarthy F, et al. A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients. BJU Int 2019. [Epub ahead of print]. 10.1111/bju.14811 - DOI - PMC - PubMed